Vetnostrum Animal Health Co., Ltd.

6936 · TW · Consumer Defensive / Farm Products

32.10TWD+0.10 (+0.31%)

Price History

Full chart

Market Stats

Previous Close32.00

Open31.90

Day Range31.90 – 32.20

52-Week Range31.21 – 44.17

Volume10.94K

Market Cap2.34B

P/E (TTM)14.19

Forward P/E0.00

EPS2.27

Dividend Yield4.69%

Beta0.10

50-Day Avg32.14

200-Day Avg33.90

About

Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company was founded in 2012 and is based in Hsinchu City, Taiwan. Vetnostrum Animal Health Co., Ltd. operates as a subsidiary of YungShin Global Holding Corporation.

Company Details

SectorConsumer Defensive
IndustryFarm Products
CEOWei-Kai Chung
Employees195
HeadquartersNo. 290-3, Hsinchu City, Taiwan, 30442, Taiwan
Websitehttps://www.vetnostrum.com

Leadership

Wei-Kai ChungChairman & President
Yi-Fen ChenAccounting Supervisor and Financial & Accounting officer
Wan-Ting TsaiChief Internal Auditor

Financials

Income Statement

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.18B	1.19B	1.21B	1.29B	1.42B
Growth (%)	-	+0.78%	+1.87%	+7.17%	+9.43%
Cost of Revenue	819.06M	832.13M	850.75M	853.42M	964.25M
Gross Profit	357.16M	353.23M	356.76M	440.69M	451.87M
Gross Margin	30.37%	29.80%	29.55%	34.05%	31.91%
Operating Expense	218.22M	228.60M	245.32M	269.96M	295.75M
Operating Income	138.94M	124.63M	111.44M	170.73M	156.12M
Operating Margin	11.81%	10.51%	9.23%	13.19%	11.02%
EBITDA	-	212.15M	191.74M	246.97M	233.64M
EBITDA Margin	-	17.90%	15.88%	19.08%	16.50%
Net Income	109.90M	106.52M	91.60M	136.62M	128.85M
Net Income Margin	9.34%	8.99%	7.59%	10.56%	9.10%
R&D	20.75M	19.50M	25.46M	28.78M	34.38M
R&D as % of Total Revenue	1.76%	1.65%	2.11%	2.22%	2.43%
Interest Expense	2.43M	2.92M	1.97M	1.10M	561.00K
Interest Expense % of Total Revenue	0.21%	0.25%	0.16%	0.08%	0.04%

Balance Sheet

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.48B	1.47B	1.38B	1.44B	1.67B
Total Liabilities	514.96M	423.24M	317.58M	307.85M	315.76M
Total Equity	966.97M	1.05B	1.06B	1.13B	1.35B
Cash	79.79M	91.60M	103.91M	96.45M	121.93M
Net Debt	170.21M	98.40M	-	-	-

Cash Flow

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	126.80M	127.56M	235.49M	180.39M	288.93M
Capital Expenditure	42.23M	22.05M	15.49M	30.20M	25.65M
Free Cash Flow	84.57M	105.51M	220.00M	150.19M	263.28M
Dividends Paid	73.70M	82.50M	80.12M	68.94M	122.73M
FCF to OCF	66.70%	82.71%	93.42%	83.26%	91.12%
Dividend Paid to FCF	87.14%	78.19%	36.42%	45.91%	46.61%

Key Statistics & Ratios

Market Cap2.34B

Enterprise Value1.87B

Trailing P/E14.19

Forward P/E0.00

Price / Sales1.57

Price / Book1.74

EPS2.27

Book Value18.21

Revenue (TTM)1.49B

Gross Profit (TTM)518.88M

EBITDA253.21M

Profit Margin10.83%

Operating Margin13.10%

Return on Equity12.44%

Return on Assets7.04%

Shares Outstanding72.80M

Shares Float29.05M

Beta0.10

Dividend Yield4.69%

Dividend Rate1.51

Payout Ratio140.84%

Dividends

20261×

1.51Jun 9, 2026

20251×

1.69Jul 16, 2025

20241×

1.04Jul 10, 2024

20231×

1.21Jul 17, 2023